We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nanosyn and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN

News   Aug 13, 2009

 
Nanosyn and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN
 
 
 

RELATED ARTICLES

Artificially Produced Cells Communicate with Each Other

News

The cells, separated by fatty membranes, exchange small chemical signaling molecules to trigger more complex reactions, such as the production of RNA and other proteins.

READ MORE

Targeting Tiny "Pocket" to Treat Stroke and Seizure

News

The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.

READ MORE

Blindness Prevented in Animal Models of Retinal Degeneration

News

Using a novel patient-specific stem cell-based therapy, blindness was prevented in animal models of geographic atrophy, the advanced 'dry' form of age-related macular degeneration (AMD), which is a leading cause of vision loss among people age 65 and older.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE